PENSIERI, MARIA VITTORIA
 Distribuzione geografica
Continente #
AS - Asia 348
NA - Nord America 217
EU - Europa 71
SA - Sud America 13
AF - Africa 5
OC - Oceania 1
Totale 655
Nazione #
US - Stati Uniti d'America 213
CN - Cina 131
SG - Singapore 129
KR - Corea 34
HK - Hong Kong 25
IT - Italia 19
DE - Germania 14
BR - Brasile 12
VN - Vietnam 12
FR - Francia 7
IN - India 7
FI - Finlandia 5
GB - Regno Unito 5
JP - Giappone 5
NL - Olanda 5
RU - Federazione Russa 5
AT - Austria 4
CA - Canada 3
ID - Indonesia 3
CI - Costa d'Avorio 2
SE - Svezia 2
ZA - Sudafrica 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
IE - Irlanda 1
JO - Giordania 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
UA - Ucraina 1
Totale 655
Città #
Singapore 97
Boardman 90
Hefei 78
Ashburn 37
Seoul 34
Santa Clara 26
Hong Kong 24
Beijing 7
Los Angeles 7
Frankfurt am Main 6
Bengaluru 5
Hanoi 5
Helsinki 5
New York 5
Tokyo 5
Chandler 4
Nuremberg 4
Redondo Beach 4
Ho Chi Minh City 3
Milan 3
Pavia 3
Tongling 3
Abidjan 2
Bologna 2
Chicago 2
Dallas 2
Hyderabad 2
Jakarta 2
London 2
Munich 2
Orem 2
Palazzolo sull'Oglio 2
Riolo Terme 2
Rome 2
Salt Lake City 2
Americana 1
Amman 1
Aracaju 1
Belo Horizonte 1
Bexley 1
Biên Hòa 1
Boston 1
Buffalo 1
Carney 1
Chamical 1
Charleston 1
Chengdu 1
Chortkiv 1
City of London 1
Curitiba 1
Denver 1
Dublin 1
Düsseldorf 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Haiphong 1
Houston 1
Japeri 1
Johannesburg 1
Joinville 1
Limeira 1
Livramento do Brumado 1
Mombello di Torino 1
Montreal 1
Nanjing 1
Nha Trang 1
Panama City 1
Pekanbaru 1
Portsmouth 1
San Pietro in Casale 1
Seattle 1
Shanghai 1
Sombrio 1
Stockholm 1
Sydney 1
São Bento do Sul 1
São José 1
São Paulo 1
Vienna 1
Villarsiviriaux 1
Warsaw 1
Yên Bái 1
Totale 529
Nome #
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis 184
Radiotherapy and palliative care outpatient clinic: a new healthcare integrated model in Italy 104
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406] 103
Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy 101
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study 59
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 43
The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy 40
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 39
Totale 673
Categoria #
all - tutte 2.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202313 0 0 0 1 1 4 0 1 5 1 0 0
2023/202435 2 3 0 3 0 4 3 7 2 7 4 0
2024/2025246 5 29 12 14 30 19 7 6 2 24 34 64
2025/2026379 56 80 55 49 61 78 0 0 0 0 0 0
Totale 673